n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine has been researched along with mdl 72527 in 1 studies
Studies (n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine) | Trials (n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine) | Recent Studies (post-2010) (n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine) | Studies (mdl 72527) | Trials (mdl 72527) | Recent Studies (post-2010) (mdl 72527) |
---|---|---|---|---|---|
14 | 0 | 0 | 84 | 0 | 13 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casero, RA; Ha, HC; Woster, PM; Yager, JD | 1 |
1 other study(ies) available for n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine and mdl 72527
Article | Year |
---|---|
The role of polyamine catabolism in polyamine analogue-induced programmed cell death.
Topics: Acetyltransferases; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma, Non-Small-Cell Lung; Catalase; DNA Fragmentation; DNA, Neoplasm; Humans; Lung Neoplasms; Oxidoreductases Acting on CH-NH Group Donors; Polyamines; Putrescine; Tumor Cells, Cultured | 1997 |